We also found that Imprime-bound DC had elevated levels of activation markers even in the presence of BxPC-3-TCM demonstrating that Imprime could potentially be able to counter VEGF’s ability to hamper differentiation of DCs in the tumor microenvironment (Supplementary Figure 5C). This evidence concerns the gene VEGFA and neoplasm.